PREDNISONE | A210785 | STRIDES PHARMA GLOBAL PTE LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Strides Pharma Inc FDA-2017-P-4027 · 5 docket documents Strides Pharma Inc. submitted this citizen petition requesting that the FDA determine whether Schering Corp's METICORTEN (Prednisone) Tablets 1 mg and 5 mg, approved under NDA N009766, were discontinued for safety or effectiveness reasons, and if not, to accept and approve Strides' ANDA 210785 for P | 505(q) | 2017-07-03 | Granted | Strides Pharma Inc |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.0421
per ea
Lowest NADAC/Unit
$0.0421
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64380078206PREDNISONE 1 MG TABLET | $0.0421 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.